A Novo Nordisk executive collapsed during President Trump’s announcement about lowering the cost of weight loss drugs like ...

Danish company is battling with Pfizer for US biotech as they seek edge in growing market for weight-loss drugs ...

President Trump promised to lower the cost of Ozempic. Mark Cuban says he's working from the same playbook as Cost Plus, ...

Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs ...

The Trump administration announced its newest pharmaceutical agreement under its Most Favored Nation policy Thursday, ...

Eli Lilly and Novo Nordisk are cutting prices for popular weight-loss drugs in deals struck with the Trump administration, ...

Popular GLP-1 drugs like Ozempic will get cheaper in exchange for partial Medicare coverage, opening up new markets for Eli ...

Even after Trump’s new deal, obesity drugs are still too expensive.

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

US President Donald Trump’s Oval Office press conference on Thursday, which focused on slashing the prices of weight-loss ...

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...